Evaluation of Whether the Selective Progesterone Receptor Modulator CDB-2914 Can Reduce Bleeding in Premenopausal Women With Abnormal Uterine Bleeding: A Pilot Study.
Withdrawn prior to enrolment
Phase of Trial: Phase 0
Latest Information Update: 09 Apr 2018
At a glance
- Drugs Ulipristal (Primary)
- Indications Menorrhagia
- Focus Therapeutic Use
- 01 Jul 2013 Status changed from not yet recruiting to withdrawn prior to recruitment as reported by ClinicalTrials.gov.
- 21 Mar 2012 Additional lead trial investigator identified as reported by ClinicalTrials.gov.
- 31 Jan 2012 Status changed from recruiting to not yet recruiting as reported by ClinicalTrials.gov.